Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes
Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos, et al.
Clinical Cancer Research (2009) Vol. 15, Iss. 7, pp. 2238-2247
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
Ayalew Tefferi
Leukemia (2010) Vol. 24, Iss. 6, pp. 1128-1138
Open Access | Times Cited: 515
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
Stanley Lipkowitz, Allan M. Weissman
Nature reviews. Cancer (2011) Vol. 11, Iss. 9, pp. 629-643
Open Access | Times Cited: 370
Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
Rafael Bejar, Ross L. Levine, Benjamin L. Ebert
Journal of Clinical Oncology (2011) Vol. 29, Iss. 5, pp. 504-515
Open Access | Times Cited: 305
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Blood (2012) Vol. 120, Iss. 15, pp. 3080-3088
Open Access | Times Cited: 286
FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications
Julhash U. Kazi, Lars Rönnstrand
Physiological Reviews (2019) Vol. 99, Iss. 3, pp. 1433-1466
Closed Access | Times Cited: 149
Heterozygous Germline Mutations in the CBL Tumor-Suppressor Gene Cause a Noonan Syndrome-like Phenotype
Simone Martinelli, Alessandro De Luca, Emilia Stellacci, et al.
The American Journal of Human Genetics (2010) Vol. 87, Iss. 2, pp. 250-257
Open Access | Times Cited: 248
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
Mrinal M. Patnaik, Terra L. Lasho, Christy Finke, et al.
American Journal of Hematology (2012) Vol. 88, Iss. 3, pp. 201-206
Open Access | Times Cited: 144
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima, Anna Jankowska, Michael A. McDevitt, et al.
Blood (2011) Vol. 117, Iss. 21, pp. e198-e206
Open Access | Times Cited: 144
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia
Christopher Allen, Robert K. Hills, Katarina Lamb, et al.
Leukemia (2013) Vol. 27, Iss. 9, pp. 1891-1901
Closed Access | Times Cited: 137
Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of Age
Stephen C. Kales, Philip Ryan, Marion M. Nau, et al.
Cancer Research (2010) Vol. 70, Iss. 12, pp. 4789-4794
Open Access | Times Cited: 126
Current findings for recurring mutations in acute myeloid leukemia
Shinichiro Takahashi
Journal of Hematology & Oncology (2011) Vol. 4, Iss. 1
Open Access | Times Cited: 124
BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance
Hilmar Quentmeier, Sonja Eberth, Julia Romani, et al.
Journal of Hematology & Oncology (2011) Vol. 4, Iss. 1
Open Access | Times Cited: 114
Molecular Pathways: Cbl Proteins in Tumorigenesis and Antitumor Immunity—Opportunities for Cancer Treatment
Mariya Liyasova, Ke Ma, Stanley Lipkowitz
Clinical Cancer Research (2014) Vol. 21, Iss. 8, pp. 1789-1794
Open Access | Times Cited: 95
Independent prognostic variables in acute myeloid leukaemia
Matthew L. Smith, Robert K. Hills, David Grimwade
Blood Reviews (2010) Vol. 25, Iss. 1, pp. 39-51
Closed Access | Times Cited: 105
CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
Yi‐Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.
PLoS ONE (2010) Vol. 5, Iss. 1, pp. e8972-e8972
Open Access | Times Cited: 105
New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases
Federica Toffalini, Jean‐Baptiste Demoulin
Blood (2010) Vol. 116, Iss. 14, pp. 2429-2437
Open Access | Times Cited: 103
Drug resistance in mutant FLT3-positive AML
Ellen Weisberg, Martin Sattler, Arghya Ray, et al.
Oncogene (2010) Vol. 29, Iss. 37, pp. 5120-5134
Closed Access | Times Cited: 94
Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling
Chozhavendan Rathinam, Christine B.F. Thien, Richard A. Flavell, et al.
Cancer Cell (2010) Vol. 18, Iss. 4, pp. 341-352
Closed Access | Times Cited: 93
A Restricted Spectrum of Mutations in the SMAD4 Tumor-Suppressor Gene Underlies Myhre Syndrome
Viviana Caputo, L Cianetti, Marcello Niceta, et al.
The American Journal of Human Genetics (2012) Vol. 90, Iss. 1, pp. 161-169
Open Access | Times Cited: 92
Molecular Pathophysiology of Myelodysplastic Syndromes
R. Coleman Lindsley, Benjamin L. Ebert
Annual Review of Pathology Mechanisms of Disease (2011) Vol. 8, Iss. 1, pp. 21-47
Open Access | Times Cited: 87
Genetic and epigenetic alterations of myeloproliferative disorders
Jelena D. Milosevic Feenstra, Róbert Královics
International Journal of Hematology (2012) Vol. 97, Iss. 2, pp. 183-197
Open Access | Times Cited: 77
Role of CBL Mutations in Cancer and Non-Malignant Phenotype
Davide Leardini, Daria Messelodi, Edoardo Muratore, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 839-839
Open Access | Times Cited: 29
Molecular genetics in acute myeloid leukemia
Ulrike Bacher, Susanne Schnittger, Torsten Haferlach
Current Opinion in Oncology (2010) Vol. 22, Iss. 6, pp. 646-655
Closed Access | Times Cited: 74
Suppressor of Cytokine Signaling 6 (SOCS6) Negatively Regulates Flt3 Signal Transduction through Direct Binding to Phosphorylated Tyrosines 591 and 919 of Flt3
Julhash U. Kazi, Jianmin Sun, Bengt Phung, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 43, pp. 36509-36517
Open Access | Times Cited: 71
Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies
Ulrike Bacher, Claudia Haferlach, Susanne Schnittger, et al.
Annals of Hematology (2010) Vol. 89, Iss. 7, pp. 643-652
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top